PI Health Sciences completed the acquisition of Therachem Research Medilab and Solis Pharmachem for $75m.

PI Health Sciences, a pharmaceutical service provider, completed the acquisition of Therachem Research Medilab, a service provider for pharmaceutical and biopharmaceutical companies, and Solis Pharmachem, a specialty pharmaceutical company, for $75m.